CRISPR Therapeutics (CRSP) Prices 6.428M Share Common Offering at $70/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
Go back to CRISPR Therapeutics (CRSP) Prices 6.428M Share Common Offering at $70/Sh
June 30, 2020 9:27 AM EDT
Pre-Open Stock Movers
Carver Bancorp (NASDAQ: CARV) 174.6% HIGHER; higher after Netflix said it will allocate $100M in cash to black community banks.
Broadway Financial (NASDAQ: BYFC) 88% HIGHER; higher after Netflix said it will allocate $100M in cash to black community banks.
Blink Charging (NASDAQ: BLNK) 54% HIGHER; sees added momentum
Oncocyte Corporation (NYSE:... More
June 29, 2020 6:05 PM EDT
After-Hours Stock Movers
Qumu Corporation (Nasdaq: QUMU) 18.8% HIGHER; Synacor and Qumu announced that the companies have mutually agreed to terminate their proposed all-stock merger agreement, previously announced on February 11, 2020.
Liquidia Technologies, Inc. (NASDAQ: LQDA) 18.1% LOWER; announced today that it has commenced an underwritten public offering of its common stock
Synacor, Inc. (Nasdaq: SYNC) 8% LOWER; Synacor and Qumu Corporation (Nasdaq: QUMU) announced that the companies have... More
June 29, 2020 4:02 PM EDT
CRISPR Therapeutics (NASDAQ: CRSP) today announced that it is commencing an underwritten public offering of $325,000,000 of common shares. In addition, the underwriters will have a 30-day option to purchase up to an additional $48,750,000 of common shares at the public offering price less the... More
June 29, 2020 8:59 AM EDT
Piper Sandler analyst Edward Tenthoff reiterated an Overweight rating and $104.00 price target on CRISPR Therapeutics (NASDAQ: CRSP) citing a new manufacturing facility to produce cell therapies for clinical and commercial use, the hiring of up to 100 more full-time employees, Car-T advancing, and AACR II showing superior features of Allo Car-T Pipeline.
The... More
